Skip to main content

Day: October 17, 2024

CX360, Inc. Supports FCC Ruling to Require Georouting for Wireless Calls to the 988 Suicide & Crisis Lifeline

Decision to uphold centralized routing system underscores the 988 Lifeline’s mission to deliver a consistently high standard of mental health and crisis care OMAHA, Neb., Oct. 17, 2024 (GLOBE NEWSWIRE) — CX360, Inc. (“Mosaicx”), a conversational AI pioneer, applauds today’s decision by the Federal Communications Commission (FCC) to adopt a new regulation requiring georouting for wireless calls to the 988 Suicide & Crisis Lifeline. This decision enables help seekers to receive localized care, maintains the 988 Lifeline’s centralized routing system and promotes a uniform standard of care for people experiencing a mental health crisis. Mosaicx provides the intelligent routing technology that supports both georouting and routing of calls from all help seekers, ensuring specialized crisis care and resources for diverse communities,...

Continue reading

Osisko Mining Shareholders Overwhelmingly Approve Acquisition by Gold Fields

TORONTO, Oct. 17, 2024 (GLOBE NEWSWIRE) — Osisko Mining Inc. (“Osisko“) (TSX:OSK) is pleased to announce that shareholders of Osisko (“Shareholders“) overwhelmingly approved the Arrangement Resolution (as defined herein) at the special meeting of Shareholders (the “Meeting“) held earlier today at the Offices of Bennett Jones LLP. The Meeting was called for Shareholders to consider and, if deemed advisable, approve the previously-announced plan of arrangement of Osisko (the “Plan of Arrangement“), pursuant to which Gold Fields Limited, through a 100% owned Canadian subsidiary (the “Purchaser” or “Gold Fields“), would, among other things, acquire all of the issued and outstanding common shares of Osisko (“Osisko Shares“) for cash consideration of...

Continue reading

VEON Files its 2023 Form 20-F

Amsterdam, 17 October 2024, 20:45: VEON Ltd. (Nasdaq: VEON, Euronext Amsterdam: VEON), a global digital operator (‘VEON’ or the ‘Company’), today announces that it has filed its Annual Report on Form 20-F for the year ended December 31, 2023 (the “2023 Form 20-F”) with the U.S. Securities and Exchange Commission at www.sec.gov following the completion of the audit of its 2023 financial statements by its independent auditor UHY LLP according to Public Company Accounting Oversight Board (“PCAOB”) standards. “The filing of our 2023 Form 20-F puts VEON back on track with our listing compliance requirements. I would like to thank our counterparts for their trust as we worked towards the completion of the PCAOB Audit for our 2023 financials and the filing of our Annual Report on Form 20-F.” said Kaan Terzioglu, Group CEO of VEON....

Continue reading

Sezzle to Announce Third Quarter 2024 Results

Minneapolis, MN, Oct. 17, 2024 (GLOBE NEWSWIRE) — Sezzle Inc. (NASDAQ:SEZL) (Sezzle or Company) // Purpose-driven digital payment platform, Sezzle, will release its third quarter 2024 results after the market close on November 07, 2024. The Company will host a conference call at 5:00pm ET that same day. Participants can register for the conference call by navigating to: https://dpregister.com/sreg/10193861/fdcca5b749 Please note that registered participants will receive their dial-in number upon registration. Investors are encouraged to submit any questions in advance of the call by emailing them to: investorrelations@sezzle.com. Contact InformationLee Brading, CFAInvestor Relations+651 240 6001investorrelations@sezzle.com Erin ForanMedia Enquiries +651 403 2184erin.foran@sezzle.comAbout Sezzle Inc. Sezzle is...

Continue reading

AB Science provides an update on the application for conditional marketing authorisation of masitinib in ALS

PRESS RELEASE AB SCIENCE PROVIDES AN UPDATE ON THE APPLICATION FOR CONDITIONAL MARKETING AUTHORISATION OF MASITINIB IN THE TREATMENT OF AMYOTROPHIC LATERAL SCLEROSIS Paris, 17 October, 2024, 7.30pm CET AB Science SA (Euronext – FR0010557264 – AB) today announces that the European Medicines Agency (EMA) confirmed a negative opinion for the conditional marketing authorization of masitinib in the treatment of amyotrophic lateral sclerosis (ALS), following a vote adopted during the Committee for Medicinal Products for Human Use (CHMP) meeting on 14-17 October 2024. The Conditional Marketing Authorization of masitinib had been under review by the CHMP in response to the company’s request for a re-examination of the negative opinion issued in June 2024. Despite the difficulty of a conditional marketing authorization in ALS, AB Science...

Continue reading

Kelso Technologies Inc. 2024-Q3 Financials Summary

VANCOUVER, British Columbia and BONHAM, Texas, Oct. 17, 2024 (GLOBE NEWSWIRE) — Kelso Technologies Inc. (“Kelso” or the “Company”), (TSX: KLS), reports that it has released its unaudited consolidated interim financial statements and Management Discussion and Analysis for the three months ended September 30 2024. The unaudited consolidated interim financial statements were prepared in accordance with International Financial Reporting Standards (“IFRS”) as issued by the International Accounting Standards Board (“IASB”). All amounts herein are expressed in United States dollars (the Company’s functional currency) unless otherwise indicated. The Company’s unaudited consolidated financial statements and MD&A for the three months ended September 30, 2024 were approved by the Board of Directors on October 16, 2024. HIGHLIGHTS:In...

Continue reading

Casino Group: Statutory buyout proceedings – Cnova

Casino has initiated statutory buyout proceedings in accordance with Article 2:92a of the Dutch Civil Code to acquire all issued shares in Cnova Paris, 17 October 2024 Casino Guichard-Perrachon S.A. (Euronext Paris: CO; ISIN: FR0000125585) hereby informs as follows: on 17 October 2024, Casino Guichard-Perrachon S.A. (“Casino“) has initiated statutory buyout proceedings (uitkoopprocedure) in accordance with Article 2:92a of the Dutch Civil Code (the “DCC“) at the Enterprise Chamber of the Amsterdam Court of Appeal, the Netherlands, (the “Enterprise Chamber“), for the purpose of acquiring all issued shares in Cnova N.V. (“Cnova“). This is following the judgment that FRH and Casino received from the Enterprise Chamber on 20 June 2024, in which the Enterprise Chamber granted an exemption to FRH...

Continue reading

RUBIS: Rubis completes the sale of its 55% stake in Rubis Terminal (now branded Tepsa)

Paris, 17 October 2024, 06:30pm Following the final agreement signed on 10 April 2024, Rubis has completed on 16 October 2024 the sale of its 55% stake in the Rubis Terminal JV (now branded Tepsa) to I Squared Capital. As announced previously, Rubis has received a first payment of €124 million1 at closing, c. €77 million of which will be returned to shareholders through an exceptional interim dividend for 2024 of €0.75 per share. The interim dividend will be detached on 6 November 2024 and paid on 8 November 2024. This dividend is in addition to the usual annual dividend as per the Group’s dividend policy. The remainder of the proceeds will be dedicated to the acceleration of the development of both Energy Distribution and Renewable Electricity Production businesses.    Upcoming events Q3 & 9M 2024 trading update: 5 November...

Continue reading

EssilorLuxottica: Q3/9M 2024 Revenue – Revenue keeping a solid 4% growth

Q3/9M 2024 Revenue Revenue keeping a solid 4% growthGroup’s revenue up 4.0% at constant exchange rates1 in Q3, +4.9% year to date Revenue positive in both segments in all the regions in Q3 North America up low-single digit, with sun retail turning positive at the end of the quarter EMEA up mid-single digit, driven by both Professional Solutions and Direct to Consumer China kept positive, despite macroeconomic headwinds, supported by Stellest 40% growth Ray-Ban Meta and Transitions Gen S key growth pillars, both awarded at SILMO Paris 2024 EssilorLuxottica among top-50 Companies in the Fortune’s ‘Change the World’ listParis, France (October 17, 2024 – 6:00 pm) – EssilorLuxottica announced today that consolidated revenue for the third quarter of 2024 reached Euro 6,437 million, representing a year-on-year increase of 4.0% at constant...

Continue reading

CarGurus Celebrates Opening of New Global Headquarters in Boston

As the anchor tenant at 1001 Boylston St., CarGurus debuts state-of-the-art space designed to maximize connectivity, collaboration, and innovation BOSTON, Oct. 17, 2024 (GLOBE NEWSWIRE) — CarGurus, Inc. (Nasdaq: CARG), the No. 1 visited digital auto platform for shopping, buying, and selling new and used vehicles1, today marked the opening of its new global headquarters in Boston’s Back Bay neighborhood. Located at 1001 Boylston Street, the new office underscores CarGurus’ commitment to the Boston region with a world-class space designed for the needs of today’s flexible workplace, balancing versatile collaboration areas with a variety of workspaces that support individual work preferences.“After nearly 20 years in Cambridge, CarGurus’ move to this inspiring new space represents a meaningful chapter in our growth story in the...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Cookie Notice

We use cookies to improve your experience on our website

Information we collect about your use of Goldea Capital website

Goldea Capital website collects personal data about visitors to its website.

When someone visits our websites, we use a third party service, Google Analytics, to collect standard internet log information (such as IP address and type of browser they’re using) and details of visitor behavior patterns. We do this to allow us to keep track of the number of visitors to the various parts of the sites and understand how our website is used. We do not make any attempt to find out the identities or nature of those visiting our websites. We won’t share your information with any other organizations for marketing, market research or commercial purposes and we don’t pass on your details to other websites.

Use of cookies
Cookies are small text files that are placed on your computer or other device by websites that you visit. They are widely used to make websites work, or work more efficiently, as well as to provide information to the owners of the site.